
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Medical Distributionβ
2026-04-06AHG3Form 3 filing for Zhongliang Xie, Director at Akso Health Group
This Form 3 filing reports initial beneficial ownership of securities by Zhongliang Xie, a Director at Akso Health Group. The filing indicates that Mr. Xie has acquired ownership of securities, with the `noSecuritiesOwned` field set to '1'. The reporting period and signature date are both April 6, 2026. Mr. Xieβs addre...
Small CapMedical Distribution